Home/Filings/4/0001562180-23-008578
4//SEC Filing

Noblett Karen 4

Accession 0001562180-23-008578

CIK 0001603756other

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 7:17 PM ET

Size

9.9 KB

Accession

0001562180-23-008578

Insider Transaction Report

Form 4
Period: 2023-12-26
Noblett Karen
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2023-12-28$63.28/sh7,051$446,17734,215 total
  • Sale

    Common Stock

    2023-12-26$63.00/sh949$59,78741,266 total
Footnotes (2)
  • [F1]This sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan entered into on September 15, 2023.
  • [F2]This transaction was executed in multiple trades at prices ranging from $63.00 to $63.8425. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

Axonics, Inc.

CIK 0001603756

Entity typeother

Related Parties

1
  • filerCIK 0001756240

Filing Metadata

Form type
4
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 7:17 PM ET
Size
9.9 KB